HavaH’s mission is to develop therapies with reduced side effects and early prevention of breast cancers including hormonal refractory ER+ breast cancer and metastatic cancer. Havah uses targeted modulation of the hormonal balance in the breast to achieve a more nuanced hormonal regulation than traditional hormonal therapies.
HavaH is developing innovative, proprietary hormonal therapies that aim to improve quality of life for women across the world. HavaH brings together a world-class team passionate about helping women live lives free from the suffering caused by breast pain, debilitating menopausal symptoms and breast cancer.
Havah has extensive clinical experience with T+Ai™ having generated data from more than 1,000 Australian women with breast disease through an ongoing open label cohort study, with critical safety pharmacokinetic and early efficacy data already demonstrated.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Nyroca House, 10-20 New Street, North Adelaide,south Australia 5006,australia
- Phone
- (650)799-4635
- hi****@****ics.com
- Industry
- Biotechnology
- Website
- chavah.com.au
- Keywords
- breast cancer, hormonal breast regulation, prevention of breast cancer, endocrine therapy, autoimmune breast diseases, DCIS, ER+ breast cancer, hormonal resistance.
- HQ
- North Adelaide, South Australia
Havah Therapeutics Questions
Havah Therapeutics's helpline number is (650)799-4635
Havah Therapeutics's website is chavah.com.au
Havah Therapeutics's LinkedIn profile is https://au.linkedin.com/company/chavah-pty-ltd
Havah Therapeutics has
6 employees.
View email and phone details for 6
employees at Havah Therapeutics.
Havah Therapeutics's industry is
Biotechnology
Havah Therapeutics's top competitors are
Maha Global,
Airis Eye,
Marvin Holdings Llc,
Aidmei,
Alcura Ai Diagnostics Limited,
Highq Pharma,
Ucsf Breast Care Center,
Real Chemistry,
Dstillery,
Mitera Biosciences.
Havah Therapeutics's support email address is hi@havahtherapeutics.com
Havah Therapeutics's categories are Biotechnology
Havah Therapeutics's founding year is 2005
